NO830877L - Tricykliske derivater av 5,6-dihydro-11h-dibenzo-(b,e)azepin-6-on med farmakologisk aktivitet og fremgangsmaate for deres fremstilling - Google Patents
Tricykliske derivater av 5,6-dihydro-11h-dibenzo-(b,e)azepin-6-on med farmakologisk aktivitet og fremgangsmaate for deres fremstillingInfo
- Publication number
- NO830877L NO830877L NO830877A NO830877A NO830877L NO 830877 L NO830877 L NO 830877L NO 830877 A NO830877 A NO 830877A NO 830877 A NO830877 A NO 830877A NO 830877 L NO830877 L NO 830877L
- Authority
- NO
- Norway
- Prior art keywords
- group
- alkyl
- dibenzo
- dihydro
- sub
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 11
- 238000002360 preparation method Methods 0.000 title claims description 4
- 230000000144 pharmacologic effect Effects 0.000 title description 3
- QAYPFHIZJSDUSF-UHFFFAOYSA-N azepin-3-one Chemical compound O=C1C=CC=CN=C1 QAYPFHIZJSDUSF-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 17
- 150000001875 compounds Chemical class 0.000 claims abstract description 16
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 6
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 5
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 4
- 125000005843 halogen group Chemical group 0.000 claims abstract description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 4
- 125000004430 oxygen atom Chemical group O* 0.000 claims abstract description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 3
- 239000001257 hydrogen Substances 0.000 claims abstract description 3
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims abstract 2
- RVIYKWBRXBOCKA-UHFFFAOYSA-N 5-methylbenzo[c][1]benzazepine-6,11-dione Chemical compound O=C1N(C)C2=CC=CC=C2C(=O)C2=CC=CC=C21 RVIYKWBRXBOCKA-UHFFFAOYSA-N 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- NBMZFZYJLLEMDG-UHFFFAOYSA-N 5,11-dihydrobenzo[c][1]benzazepin-6-one Chemical class O=C1NC2=CC=CC=C2CC2=CC=CC=C12 NBMZFZYJLLEMDG-UHFFFAOYSA-N 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- -1 5,6-dihydro-11H-dibenzo-(b,e)-azepin-6-one compound Chemical class 0.000 claims 3
- USJALFVAJSYMSN-UHFFFAOYSA-N 5h-benzo[c][1]benzazepine-6,11-dione Chemical compound O=C1NC2=CC=CC=C2C(=O)C2=CC=CC=C12 USJALFVAJSYMSN-UHFFFAOYSA-N 0.000 claims 1
- 238000006546 Horner-Wadsworth-Emmons reaction Methods 0.000 claims 1
- 150000004703 alkoxides Chemical class 0.000 claims 1
- 150000001348 alkyl chlorides Chemical class 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 150000008064 anhydrides Chemical class 0.000 claims 1
- 125000003435 aroyl group Chemical group 0.000 claims 1
- 150000004820 halides Chemical class 0.000 claims 1
- 239000012948 isocyanate Substances 0.000 claims 1
- 150000002901 organomagnesium compounds Chemical class 0.000 claims 1
- 210000003169 central nervous system Anatomy 0.000 abstract description 4
- 230000001773 anti-convulsant effect Effects 0.000 abstract description 2
- 239000001961 anticonvulsive agent Substances 0.000 abstract description 2
- 229960003965 antiepileptics Drugs 0.000 abstract description 2
- 230000001624 sedative effect Effects 0.000 abstract description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- 239000000203 mixture Substances 0.000 description 8
- 238000005160 1H NMR spectroscopy Methods 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- XEKOWRVHYACXOJ-UHFFFAOYSA-N ethyl acetate Substances CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- BUGOBKVCGVQZLK-UHFFFAOYSA-N 10-amino-5h-benzo[c][1]benzazepine-6,11-dione Chemical compound O=C1C2=CC=CC=C2NC(=O)C2=C1C(N)=CC=C2 BUGOBKVCGVQZLK-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 241000906446 Theraps Species 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- KHUFHLFHOQVFGB-UHFFFAOYSA-N 1-aminoanthracene-9,10-dione Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C=CC=C2N KHUFHLFHOQVFGB-UHFFFAOYSA-N 0.000 description 1
- IGNMTKJSFDKQLE-UHFFFAOYSA-N 11-hydroxy-5-methyl-11h-benzo[c][1]benzazepin-6-one Chemical compound O=C1N(C)C2=CC=CC=C2C(O)C2=CC=CC=C21 IGNMTKJSFDKQLE-UHFFFAOYSA-N 0.000 description 1
- IYGYMKDQCDOMRE-QRWMCTBCSA-N Bicculine Chemical compound O([C@H]1C2C3=CC=4OCOC=4C=C3CCN2C)C(=O)C2=C1C=CC1=C2OCO1 IYGYMKDQCDOMRE-QRWMCTBCSA-N 0.000 description 1
- 208000009132 Catalepsy Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 108010040201 Polymyxins Proteins 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010047853 Waxy flexibility Diseases 0.000 description 1
- AIROWKHOMTWHBV-UHFFFAOYSA-N [1-amino-2-(2,6-dichlorophenyl)ethylidene]urea;hydrochloride Chemical compound Cl.NC(=O)\N=C(/N)CC1=C(Cl)C=CC=C1Cl AIROWKHOMTWHBV-UHFFFAOYSA-N 0.000 description 1
- YAXGXEOYWAIEER-UHFFFAOYSA-N acetic acid;triethylphosphane Chemical compound CC([O-])=O.CC[PH+](CC)CC YAXGXEOYWAIEER-UHFFFAOYSA-N 0.000 description 1
- KLSKLNWJEDXFSD-UHFFFAOYSA-N adosopine Chemical compound O=C1C2=CC=CC=C2N(C)C(=O)C2=C1C(NC(=O)C)=CC=C2 KLSKLNWJEDXFSD-UHFFFAOYSA-N 0.000 description 1
- AACMFFIUYXGCOC-UHFFFAOYSA-N bicuculline Natural products CN1CCc2cc3OCOc3cc2C1C4OCc5c6OCOc6ccc45 AACMFFIUYXGCOC-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- IYGYMKDQCDOMRE-UHFFFAOYSA-N d-Bicucullin Natural products CN1CCC2=CC=3OCOC=3C=C2C1C1OC(=O)C2=C1C=CC1=C2OCO1 IYGYMKDQCDOMRE-UHFFFAOYSA-N 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- HAMGRBXTJNITHG-UHFFFAOYSA-N methyl isocyanate Chemical compound CN=C=O HAMGRBXTJNITHG-UHFFFAOYSA-N 0.000 description 1
- MSAJFKFUVLSHHZ-UHFFFAOYSA-N n-(5-methyl-6,11-dioxobenzo[c][1]benzazepin-10-yl)benzamide Chemical compound C1=CC=C2C(=O)N(C)C3=CC=CC=C3C(=O)C2=C1NC(=O)C1=CC=CC=C1 MSAJFKFUVLSHHZ-UHFFFAOYSA-N 0.000 description 1
- 235000020323 palazzo Nutrition 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000012345 traction test Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/20—Dibenz [b, e] azepines; Hydrogenated dibenz [b, e] azepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT8209356A IT1207417B (it) | 1982-03-15 | 1982-03-15 | Azepina-6-one ad attivita'composti triciclici derivati dalla farmacologica, e procedimenti di 5,6-diidro-11h-dibenzo (b,e)fabbricazione relativi |
Publications (1)
Publication Number | Publication Date |
---|---|
NO830877L true NO830877L (no) | 1983-09-16 |
Family
ID=11128909
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO830877A NO830877L (no) | 1982-03-15 | 1983-03-14 | Tricykliske derivater av 5,6-dihydro-11h-dibenzo-(b,e)azepin-6-on med farmakologisk aktivitet og fremgangsmaate for deres fremstilling |
Country Status (22)
Country | Link |
---|---|
US (1) | US4551451A (da) |
EP (1) | EP0089322B1 (da) |
JP (1) | JPS58180471A (da) |
AT (1) | ATE27816T1 (da) |
AU (1) | AU562360B2 (da) |
CA (1) | CA1226282A (da) |
DD (1) | DD209452A5 (da) |
DE (1) | DE3217236C2 (da) |
DK (1) | DK158722C (da) |
ES (1) | ES8407479A1 (da) |
GB (1) | GB2116539B (da) |
GR (1) | GR78455B (da) |
HU (1) | HU189671B (da) |
IE (1) | IE54859B1 (da) |
IT (1) | IT1207417B (da) |
MX (1) | MX156434A (da) |
NO (1) | NO830877L (da) |
PL (3) | PL241018A1 (da) |
PT (1) | PT76372B (da) |
SU (1) | SU1301830A1 (da) |
YU (1) | YU63083A (da) |
ZA (1) | ZA831473B (da) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0665664B2 (ja) * | 1985-01-18 | 1994-08-24 | 大塚製薬株式会社 | モルフアントリジン誘導体 |
IT1233715B (it) * | 1989-07-14 | 1992-04-14 | Menarini Farma Ind | Uso in terapia della 10-ammino-5,6diidro-11h= dibenzo (b,e) azepina-6,11-dione e derivati, quali farmaci utili per il trattamento dell'incontinenza urinaria |
DE4138853A1 (de) * | 1991-11-27 | 1993-06-03 | Bayer Ag | 5,6-dihydro-dibenz(b,e)azepin-6,11-dion-11- oxime |
AU3441193A (en) * | 1992-04-14 | 1993-11-18 | Sphinx Pharmaceuticals Corporation | Polyhydroxylated dibenz (C,E) azepines as protein kinase C inhibitors |
JP2001514253A (ja) * | 1997-09-04 | 2001-09-11 | スミスクライン・ビーチャム・コーポレイション | インテグリンレセプターアンタゴニスト |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3084155A (en) * | 1963-04-02 | Derivatives of dibenzo | ||
GB972082A (en) * | 1961-06-07 | 1964-10-07 | Koninklijke Pharma Fab Nv | Dihydrodibenzazepinones |
GB1062573A (en) * | 1963-10-29 | 1967-03-22 | Colgate Palmolive Co | Morphanthridine derivatives,and processes of preparing the same |
DE1545856A1 (de) * | 1965-09-10 | 1969-11-27 | Bayer Ag | Verfahren zur Herstellung von basisch substituierten Derivaten des 5,6-Dihydro-dibenz-[b,e]-azepin-6,11-dion-11-oxims |
DE1568217A1 (de) * | 1966-12-16 | 1970-01-02 | Boehringer Mannheim Gmbh | Verfahren zur Herstellung von tricyclischen Derivaten des Acetamids |
JPS4934996B1 (da) * | 1969-05-06 | 1974-09-19 | ||
CH569730A5 (da) * | 1972-04-04 | 1975-11-28 | Wander Ag Dr A | |
CH577975A5 (da) * | 1972-10-20 | 1976-07-30 | Sandoz Ag | |
DE2361467A1 (de) * | 1973-12-10 | 1975-06-19 | Thiemann Chem Pharm Fab | 1-amino-5,6-dihydro-morphanthridin5,11-dion-verbindungen und solche verbindungen enthaltende arzneimittel |
CH601287A5 (da) * | 1975-08-06 | 1978-07-14 | Sandoz Ag | |
DE2918778A1 (de) * | 1979-05-10 | 1980-11-20 | Basf Ag | 6-substituierte 11-alkylen-morphantridine |
DE2918832A1 (de) * | 1979-05-10 | 1980-11-20 | Basf Ag | 5,6-dihydro-11-alkylen-morphantridin- 6-one |
DE3113094A1 (de) * | 1981-04-01 | 1982-10-21 | Basf Ag, 6700 Ludwigshafen | 5,6-dihydro-11-alkylen-morphantridin-6-one, ihre herstellung und diese enthaltende arzneimittel |
-
1982
- 1982-03-15 IT IT8209356A patent/IT1207417B/it active
- 1982-05-07 DE DE3217236A patent/DE3217236C2/de not_active Expired - Fee Related
- 1982-05-12 GB GB08213840A patent/GB2116539B/en not_active Expired
-
1983
- 1983-02-24 DK DK086483A patent/DK158722C/da not_active IP Right Cessation
- 1983-03-04 ZA ZA831473A patent/ZA831473B/xx unknown
- 1983-03-10 PT PT76372A patent/PT76372B/pt unknown
- 1983-03-11 CA CA000423451A patent/CA1226282A/en not_active Expired
- 1983-03-11 AU AU12431/83A patent/AU562360B2/en not_active Ceased
- 1983-03-14 PL PL24101883A patent/PL241018A1/xx unknown
- 1983-03-14 JP JP58040825A patent/JPS58180471A/ja active Granted
- 1983-03-14 ES ES520577A patent/ES8407479A1/es not_active Expired
- 1983-03-14 IE IE542/83A patent/IE54859B1/en unknown
- 1983-03-14 EP EP83830056A patent/EP0089322B1/en not_active Expired
- 1983-03-14 AT AT83830056T patent/ATE27816T1/de not_active IP Right Cessation
- 1983-03-14 HU HU83858A patent/HU189671B/hu not_active IP Right Cessation
- 1983-03-14 PL PL1983252303A patent/PL140327B1/pl unknown
- 1983-03-14 NO NO830877A patent/NO830877L/no unknown
- 1983-03-14 GR GR70782A patent/GR78455B/el unknown
- 1983-03-14 SU SU833565650A patent/SU1301830A1/ru active
- 1983-03-15 YU YU00630/83A patent/YU63083A/xx unknown
- 1983-03-15 MX MX196578A patent/MX156434A/es unknown
- 1983-03-15 DD DD83248814A patent/DD209452A5/de not_active IP Right Cessation
-
1984
- 1984-03-14 PL PL25230384A patent/PL252303A1/xx unknown
- 1984-08-10 US US06/639,687 patent/US4551451A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DK86483D0 (da) | 1983-02-24 |
GB2116539A (en) | 1983-09-28 |
DD209452A5 (de) | 1984-05-09 |
JPH0480027B2 (da) | 1992-12-17 |
IT8209356A0 (it) | 1982-03-15 |
CA1226282A (en) | 1987-09-01 |
SU1301830A1 (ru) | 1987-04-07 |
EP0089322B1 (en) | 1987-06-16 |
IE830542L (en) | 1983-09-15 |
YU63083A (en) | 1989-08-31 |
DK86483A (da) | 1983-09-16 |
GB2116539B (en) | 1986-04-30 |
ZA831473B (en) | 1983-11-30 |
AU562360B2 (en) | 1987-06-11 |
US4551451A (en) | 1985-11-05 |
IE54859B1 (en) | 1990-02-28 |
AU1243183A (en) | 1983-09-22 |
DK158722C (da) | 1990-12-03 |
ES520577A0 (es) | 1984-10-01 |
PL252303A1 (en) | 1985-12-17 |
IT1207417B (it) | 1989-05-17 |
DE3217236A1 (de) | 1983-09-15 |
PT76372B (en) | 1985-12-05 |
PL241018A1 (en) | 1985-07-16 |
JPS58180471A (ja) | 1983-10-21 |
DK158722B (da) | 1990-07-09 |
ATE27816T1 (de) | 1987-07-15 |
EP0089322A1 (en) | 1983-09-21 |
PL140327B1 (en) | 1987-04-30 |
MX156434A (es) | 1988-08-22 |
PT76372A (en) | 1983-04-01 |
HU189671B (en) | 1986-07-28 |
DE3217236C2 (de) | 1994-04-14 |
ES8407479A1 (es) | 1984-10-01 |
GR78455B (da) | 1984-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4855298A (en) | 6-Halo-1,2,3,4-tetrahydroquinazoline-4-spiro-4-imidazolidine-2,2'5'-triones useful for the treatment and prophylaxis of diabetic complications | |
CS225802B2 (en) | The production of new 4-/polyalkoxyphenoy 1/-2-pyrrolidone | |
EP0104522B1 (en) | New pyrazolo(3,4-b)pyridine derivatives and process for producing them | |
RU2024522C1 (ru) | Производные дипиридо-диазепина и их фармакологически переносимые соли, обладающие биологической активностью | |
EP0126968B1 (en) | Ergoline derivatives, processes for their preparation and pharmaceutical compositions containing same | |
EP0541807B1 (en) | Novel benzopyran derivative | |
US4213985A (en) | Novel 5,11-dihydro-6H-pyrido-[2,3-b][1,4]-benzodiazepine-6-ones | |
US4066665A (en) | 2-Alkylamino-α-phenyl-1-cyclohexene-1-methyleneimine, its salts and preparation | |
HU206873B (en) | Process for producing 9-amino-benzodiazepine derivatives | |
NO830877L (no) | Tricykliske derivater av 5,6-dihydro-11h-dibenzo-(b,e)azepin-6-on med farmakologisk aktivitet og fremgangsmaate for deres fremstilling | |
US4091037A (en) | Preparation of alkylthiomethylphenols | |
US4046778A (en) | Processes for the preparation of 4-hydroxy-2H-1-benzothiopyran-3-carboxamide 1,1-dioxides | |
AU616608B2 (en) | 4,5,6,7-tetrasubstituted benzoxazolones | |
Huckle et al. | 4-Amino-2, 3, 4, 5-tetrahydro-1-benzoxepin-5-ols, 4-amino-2, 3, 4, 5-tetrahydro-1-benzothiepin-5-ols, and related compounds | |
NO132201B (da) | ||
US3461131A (en) | Process for preparing 2-substituted cycloheptimidazole derivatives | |
US3320272A (en) | Process for preparing z-alkoxycyclo- heptimidazole derivatives | |
IL26416A (en) | History of 6,5 - Dihydro - Divance - [e, b] - Azpine-6, 11 - 11 - Basic-transformed oxen | |
EP0033214A2 (en) | Process for preparing therapeutically active triazoles | |
US5162529A (en) | Process for the preparation of 5-hydroxy-3,4,5,6-tetrahydro-pyrimidine derivatives | |
EP0015786B1 (fr) | Imidazo et pyrimido-pyrido-indoles, leur préparation et médicaments les contenant | |
NO132800B (da) | ||
Gstach et al. | Rearrangement of 3, 3-Disubstituted 1-Aryl-4, 5-dihydro-5-oxo-3H-1, 2, 4-triazolium Tetrafluoroborates; Part 3. An Efficient Synthesis of 1, 5-Heteroannulated 1, 2-Dihydro-2-phenyl-3H-1, 2, 4-triazol-3-ones | |
US4421756A (en) | Quinolinoneimine carboxylic acid anti-inflammatory and analgesic composition containing the compound | |
KR790001432B1 (ko) | 티아졸리닐 또는 티아지닐 벤즈이미다졸 에스테르의 제조방법 |